Role of oxidative mechanisms in the pathogenesis of age-related macular degeneration;Mechanizmy oksydacyjne w patogenezie zwyrodnienia plamki zwia̧zanego z wiekiem

Klinika Oczna

Volumn 111, Issue 4-6, 2009, Pages 168-173

  Janik Papis, Katarzyna ^a   Ulińska, Magdalena ^b   Krzyzanowska, Anna ^a   Stoczyńska, Ewelina ^a   Borucka, Anna I ^b   Woźniak, Katarzyna ^a   Zaraś, Małgorzata ^b   Szaflik, Jacek P ^b   Błasiak, Janusz ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b Samodzielnego Publicznego Klinicznego Szpitala Okulistycznego w Warszawie   (Poland)

Author keywords

Age related macular degeneration; AMD; Antioxidants; DNA repair; Oxidative stress

Indexed keywords

OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE;

AGING; BRUCH MEMBRANE; HUMAN; METABOLISM; OXIDATIVE STRESS; PIGMENT EPITHELIUM; RETINA; RETINA MACULA DEGENERATION; REVIEW; SMOKING; SUNLIGHT;

AGING; BRUCH MEMBRANE; HUMANS; MACULAR DEGENERATION; OXIDANTS; OXIDATIVE STRESS; PIGMENT EPITHELIUM OF EYE; REACTIVE OXYGEN SPECIES; RETINA; SMOKING; SUNLIGHT;

EID: 70349231491     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Age-Related Eye Disease Research Group: A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8 Arch. Ophthalmol 2001, 119, 1417-1436.
2. Ambati J, Ambati BK, Yoo SH, lanchulev S, Adamis AP: Agerelated macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003, 48, 257-293. (Pubitemid 36553096)
3. Beatty S, Koh H, Phil M, Henson D, Boulton M: The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000, 45, 115-134.
4. Sundelin SP, Nilsson SE: Lipofuscin - formation in retinal pigment epithelial cells is reduced by antioxidants. Free Radic Biol Med 2001, 31, 217-225. (Pubitemid 32607588)
5. Mori K, Duh E, Gehlbach P, Ando A, Takahashi K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D, Brough DE, Wei LL, Campochiaro PA: Pigment epithelium-derived growth factor inhibits retinal and choroidal neovascularization. J Cell Physiol 2001, 188, 253-263. (Pubitemid 32622916)
6. Taylor HR, Tikellis G, Robman LD, McCarty CA, McNeil JJ: Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ 2002, 325, 11-14. (Pubitemid 34747932)
7. Christen WG, Manson JE, Glynn RJ, Gaziano JM, Chew EY, Buring JE, Hennekens CH: Beta carotene supplementation and agerelated maculopathy in a randomized trial of U. S. physicians. Arch Ophthalmol 2007, 125, 333-339. (Pubitemid 46425560)
8. Hogg R, Chakravarthy U: Age related macular degeneration and micronutrient antioxidants. Curr Eye Res 2004, 29, 387-401.
9. Richer S, Stiles W, Statkute L: Double-masked, placebocontrolled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004, 75, 216-230. (Pubitemid 39208022)
10. Kimura K, Isashiki Y, Sonoda S, Kakiuchi-Matsumoto T, Ohba N: Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 2000, 130, 769-773. (Pubitemid 32000858)
11. Decanini A, Nordgaard CL, Feng X, Ferringto DA, Olsen TW: Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration Am J Ophthalmol 2007, 143, 607-615.
12. Seddon JM, George S, Rosner B: Cigarette smoking, fish consumption, omega-3 fatty acid intake and associations with agerelated macular degeneration. The US twin study of age-related macular degeneration. Arch Ophthalmol 2006, 124, 995-1001. (Pubitemid 44036322)
13. Kikuchi M, Nakamura M, Ishikawa K, Suzuki T, Nishihara H, Yamakoshi T, Nishio K, Taki K, Niwa T, Hamajima N, Terasaki H: Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology 2007, 114, 1722-1727. (Pubitemid 47332667)
14. Erie JC, Good JA, Butz JA, Hodge DO, Pulido JS: Urinary cadmium and age-related macular degeneration. Am J Ophthalmol 2007, 144, 414-418.
15. Wong RW, Richa DC, Hahn P, Green WR, Dunaief JL: Iron toxicity as a potential factor in AMD. Retina 2007, 27, 997-1003. (Pubitemid 350303998)
16. San Giovanni JP, Chew EY, Clemons TE, Davis MD, Ferris FL 3rd, Gensler GR, Kurinij N, Lindblad AS, Milton RC, Seddon JM, Sperduto RD: The relationship of dietary lipid intake and agerelated macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol 2007, 125, 671-679. (Pubitemid 46762729)
17. Robman L, Vu H, Hodge A, Tikellis G, Dimitrov P, McCarty C, Guymer R: Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can J Ophthalmol 2007, 42, 720-726. (Pubitemid 350157561)
18. Sparrow JR, Boulton M: RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res 2005, 80, 595-606. (Pubitemid 40602960)
19. Plestina-Borjan I, Klinger-Lasic M: Long-term exposure to solar ultraviolet radiation as a risk factor for age-related macular degeneration. Coll Antropol 2007, 31, 33-38.
20. Yamada Y, Ishibashi K, Bhutto IA, Tian J, Lutty GA, Handa JT: The expression of advanced glycation endproduct receptors in RPE cells associated with basal deposits in human maculas. Exp Eye Res 2006, 82, 840-848. (Pubitemid 43170884)